XTL Biopharmaceuticals Ltd. (TASE: XTLB)
Health Care · Biotechnology · IL
₪0.02
-6.25% today · -66.7% 1Y
XTL Biopharmaceuticals Ltd. (TASE: XTLB) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.41M and employs 10 people.
Over the last twelve months the share price has lost 66.7%, trading between 0.02 and 0.05.
Tweenvest scores XTL Biopharmaceuticals Ltd. across four factors: quality 24/100, value 39/100. Its strongest factor is value.
XTLB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.41M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- ₪0.05
- 52-week low
- ₪0.02
- Avg volume (3M)
- —
- Shares outstanding
- 1.32B
- Employees
- 10
- Next earnings
- —
About XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to sourcing and advancing medicinal products aimed at treating autoimmune conditions. Its principal experimental compound, hCDR1, is primed for Phase II clinical studies, addressing systemic lupus erythematosus and Sjogren's syndrome. The company operates under a licensing agreement with Yeda Research and Development Company Limited, granting it rights for the research, development, and commercialization of hCDR1 across numerous therapeutic applications. Originally incorporated in 1993 as Xenograft Technologies Ltd., the entity rebranded as XTL Biopharmaceuticals Ltd. in July 1995 and is currently headquartered in Ramat Gan, Israel.
- ISIN
- IL0010854979
- Founded
- 1993
- Listed since
- Aug 30, 2005
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| VitaSpring Biomedical Co. Ltd.OTCPK: VSBC | $6.58M | $0.03 | — |
| AcouSort AB (publ)OM: ACOU | $6.54M | Skr3.06 | +2.00% |
| Curative Biotechnology, Inc.OTCPK: CUBT | $6.50M | $0.91 | -4.27% |
| Subgen AI AB (publ)OM: SUBGEN | $6.44M | Skr0.03 | +7.33% |
| Theracryf PlcAIM: TCF | $6.38M | £0.00 | +2.94% |
| Moleculin Biotech, Inc.NasdaqCM: MBRX | $6.33M | $6.50 | +10.36% |
| Alzamend Neuro, Inc.NasdaqCM: ALZN | $6.27M | $1.30 | -2.99% |
| Coegin Pharma ABNGM: COEGIN | $6.26M | Skr2.17 | -10.33% |
Figures last refreshed Oct 18, 2026.